Condition

Oesophagitis, Eosinophilic (2)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

GlaxoSmithKline (2)

Collaborator

Intervention

mepolizumab (2)

Study Documents

Clinical Study Report (2)

Dataset Specification (2)

Individual Participant Data Set (2)

Informed Consent Form (2)

Study Protocol (2)

Annotated Case Report Form (1)

Statistical Analysis Plan (1)

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

oesophagitis, eosinophilic

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Oesophagitis, Eosinophilic Trial in Worldwide (mepolizumab)

Completed

Oesophagitis, Eosinophilic

mepolizumab

Birmingham, Alabama
+28 more

Jun 25, 2018

Oesophagitis, Eosinophilic Trial in Olten (mepolizumab)

Completed

Oesophagitis, Eosinophilic

mepolizumab

Olten, Switzerland

GSK Investigational Site

Dec 2, 2016